Sections
Title | Starting Page | Number of Pages |
---|
1 Table of Contents | 2 | 8 |
1.1 List of Tables | 6 | 3 |
1.2 List of Figures | 9 | 1 |
2 Introduction | 10 | 2 |
2.1 Orthopedic Prosthetics Overview | 10 | 2 |
3 Products under Development | 12 | 6 |
3.1 Orthopedic Prosthetics - Pipeline Products by Stage of Development | 12 | 1 |
3.2 Orthopedic Prosthetics - Pipeline Products by Segment | 13 | 1 |
3.3 Orthopedic Prosthetics - Pipeline Products by Territory | 14 | 1 |
3.4 Orthopedic Prosthetics - Pipeline Products by Regulatory Path | 15 | 1 |
3.5 Orthopedic Prosthetics - Pipeline Products by Estimated Approval Date | 16 | 1 |
3.6 Orthopedic Prosthetics - Ongoing Clinical Trials | 17 | 1 |
4 Orthopedic Prosthetics - Pipeline Products under Development by Companies | 18 | 4 |
4.1 Orthopedic Prosthetics Companies - Pipeline Products by Stage of Development | 18 | 2 |
4.2 Orthopedic Prosthetics - Pipeline Products by Stage of Development | 20 | 2 |
5 Orthopedic Prosthetics Companies and Product Overview | 22 | 66 |
5.1 4iBIO Company Overview | 22 | 1 |
5.1.1 4iBIO Pipeline Products &Ongoing Clinical Trials Overview | 22 | 1 |
5.2 Amplitude SAS Company Overview | 23 | 1 |
5.2.1 Amplitude SAS Pipeline Products &Ongoing Clinical Trials Overview | 23 | 2 |
5.3 Bionik Laboratories Corp. Company Overview | 25 | 1 |
5.3.1 Bionik Laboratories Corp. Pipeline Products &Ongoing Clinical Trials Overview | 25 | 2 |
5.4 BionX Medical Technologies, Inc Company Overview | 27 | 1 |
5.4.1 BionX Medical Technologies, Inc Pipeline Products &Ongoing Clinical Trials Overview | 27 | 1 |
5.5 Cadence Biomedical Company Overview | 28 | 1 |
5.5.1 Cadence Biomedical Pipeline Products &Ongoing Clinical Trials Overview | 28 | 2 |
5.6 Case Western Reserve University Company Overview | 30 | 1 |
5.6.1 Case Western Reserve University Pipeline Products &Ongoing Clinical Trials Overview | 30 | 1 |
5.7 Chalmers University of Technology Company Overview | 31 | 1 |
5.7.1 Chalmers University of Technology Pipeline Products &Ongoing Clinical Trials Overview | 31 | 2 |
5.8 Clemson University Company Overview | 33 | 1 |
5.8.1 Clemson University Pipeline Products &Ongoing Clinical Trials Overview | 33 | 2 |
5.9 DePuy Synthes Inc Company Overview | 35 | 1 |
5.9.1 DePuy Synthes Inc Pipeline Products &Ongoing Clinical Trials Overview | 35 | 1 |
5.10 DJO Surgical Company Overview | 36 | 1 |
5.10.1 DJO Surgical Pipeline Products &Ongoing Clinical Trials Overview | 36 | 4 |
5.11 Exactech Inc Company Overview | 40 | 1 |
5.11.1 Exactech Inc Pipeline Products &Ongoing Clinical Trials Overview | 40 | 1 |
5.12 Farus, LLC Company Overview | 41 | 1 |
5.12.1 Farus, LLC Pipeline Products &Ongoing Clinical Trials Overview | 41 | 1 |
5.13 Florida State University Company Overview | 42 | 1 |
5.13.1 Florida State University Pipeline Products &Ongoing Clinical Trials Overview | 42 | 2 |
5.14 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV Company Overview | 44 | 1 |
5.14.1 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV Pipeline Products &Ongoing Clinical Trials Overview | 44 | 2 |
5.15 Freedom Innovations, LLC. Company Overview | 46 | 1 |
5.15.1 Freedom Innovations, LLC. Pipeline Products &Ongoing Clinical Trials Overview | 46 | 1 |
5.16 Ghent University Company Overview | 47 | 1 |
5.16.1 Ghent University Pipeline Products &Ongoing Clinical Trials Overview | 47 | 1 |
5.17 Illini Prosthetic Technologies Company Overview | 48 | 1 |
5.17.1 Illini Prosthetic Technologies Pipeline Products &Ongoing Clinical Trials Overview | 48 | 2 |
5.18 Infinite Biomedical Technologies LLC Company Overview | 50 | 1 |
5.18.1 Infinite Biomedical Technologies LLC Pipeline Products &Ongoing Clinical Trials Overview | 50 | 2 |
5.19 Innovative Medical Device Solutions Company Overview | 52 | 1 |
5.19.1 Innovative Medical Device Solutions Pipeline Products &Ongoing Clinical Trials Overview | 52 | 1 |
5.20 James Cook University Company Overview | 53 | 1 |
5.20.1 James Cook University Pipeline Products &Ongoing Clinical Trials Overview | 53 | 2 |
5.21 John Hopkins University Company Overview | 55 | 1 |
5.21.1 John Hopkins University Pipeline Products &Ongoing Clinical Trials Overview | 55 | 4 |
5.22 Martin Bionics, LLC Company Overview | 59 | 1 |
5.22.1 Martin Bionics, LLC Pipeline Products &Ongoing Clinical Trials Overview | 59 | 1 |
5.23 National University of Singapore Company Overview | 60 | 1 |
5.23.1 National University of Singapore Pipeline Products &Ongoing Clinical Trials Overview | 60 | 1 |
5.24 North Carolina State University Company Overview | 61 | 1 |
5.24.1 North Carolina State University Pipeline Products &Ongoing Clinical Trials Overview | 61 | 2 |
5.25 Northwestern University Company Overview | 63 | 1 |
5.25.1 Northwestern University Pipeline Products &Ongoing Clinical Trials Overview | 63 | 4 |
5.26 Psyonic, Inc. Company Overview | 67 | 1 |
5.26.1 Psyonic, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 67 | 1 |
5.27 Scott Sabolich Inc Company Overview | 68 | 1 |
5.27.1 Scott Sabolich Inc Pipeline Products &Ongoing Clinical Trials Overview | 68 | 2 |
5.28 Simbex Company Overview | 70 | 1 |
5.28.1 Simbex Pipeline Products &Ongoing Clinical Trials Overview | 70 | 2 |
5.29 Stanmore Implants Worldwide Ltd. Company Overview | 72 | 1 |
5.29.1 Stanmore Implants Worldwide Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 72 | 1 |
5.30 Tavor Medical Ltd Company Overview | 73 | 1 |
5.30.1 Tavor Medical Ltd Pipeline Products &Ongoing Clinical Trials Overview | 73 | 1 |
5.31 The Chinese University of Hong Kong Company Overview | 74 | 1 |
5.31.1 The Chinese University of Hong Kong Pipeline Products &Ongoing Clinical Trials Overview | 74 | 1 |
5.32 Trinity College Dublin Company Overview | 75 | 1 |
5.32.1 Trinity College Dublin Pipeline Products &Ongoing Clinical Trials Overview | 75 | 1 |
5.33 University of Cape Town Company Overview | 76 | 1 |
5.33.1 University of Cape Town Pipeline Products &Ongoing Clinical Trials Overview | 76 | 1 |
5.34 University of Pittsburgh Company Overview | 77 | 1 |
5.34.1 University of Pittsburgh Pipeline Products &Ongoing Clinical Trials Overview | 77 | 2 |
5.35 University of South Florida Company Overview | 79 | 1 |
5.35.1 University of South Florida Pipeline Products &Ongoing Clinical Trials Overview | 79 | 2 |
5.36 Vanderbilt University Company Overview | 81 | 1 |
5.36.1 Vanderbilt University Pipeline Products &Ongoing Clinical Trials Overview | 81 | 2 |
5.37 Worcester Polytechnic Institute Company Overview | 83 | 1 |
5.37.1 Worcester Polytechnic Institute Pipeline Products &Ongoing Clinical Trials Overview | 83 | 1 |
5.38 Yale University Company Overview | 84 | 1 |
5.38.1 Yale University Pipeline Products &Ongoing Clinical Trials Overview | 84 | 2 |
5.39 Zimmer Biomet Holdings Inc Company Overview | 86 | 1 |
5.39.1 Zimmer Biomet Holdings Inc Pipeline Products &Ongoing Clinical Trials Overview | 86 | 2 |
6 Orthopedic Prosthetics- Recent Developments | 88 | 33 |
6.1 Nov 15, 2016: Bionik Laboratories Reports Second Quarter Fiscal Year 2017 Financial Results | 88 | 1 |
6.2 Nov 09, 2016: Corentec to Raise USD17.6 Million in Private Placement of Bonds Due 2021 | 89 | 1 |
6.3 Nov 08, 2016: Mazor Robotics Reports Third Quarter Financial Results | 89 | 1 |
6.4 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results | 90 | 1 |
6.5 Oct 31, 2016: Exactech Q3 Revenue Up 7% to $59.9 Million. Net Income up 10% to $3.2 Million. Diluted EPS $0.22 vs. $0.20. | 91 | 1 |
6.6 Oct 28, 2016: Results for the fourth quarter and the fiscal year ended June 30, 2016 - Ergoresearch reports its 2016 annual results | 92 | 1 |
6.7 Oct 27, 2016: Bionik Laboratories Provides Corporate Update and Business Outlook | 93 | 3 |
6.8 Oct 26, 2016: Ossur Hf: Q3 Results 2016 | 96 | 1 |
6.9 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results | 96 | 2 |
6.10 Sep 19, 2016: Cerapedics Raises USD11 Million in Series D Financing | 98 | 1 |
6.11 Sep 15, 2016: Ardian Plans to Acquire Majority Stake in Lagarrigue | 98 | 1 |
6.12 Sep 01, 2016: LegWorks Raises Funds through Venture Financing | 98 | 1 |
6.13 Aug 16, 2016: Bionik Laboratories Reports First Quarter Fiscal Year 2017 Financial Results and Provides Business Update | 98 | 1 |
6.14 Aug 08, 2016: Bionik Laboratories Appoints Timothy A. McCarthy as Chief Commercialization Officer and Expands Commercial Team | 99 | 1 |
6.15 Aug 02, 2016: Mazor Robotics Reports Second Quarter Financial Results | 100 | 1 |
6.16 Aug 01, 2016: Exactech Q2 Revenue Up 8% to $66.1 Million; Net Income up 20% to $4.4 Million; Diluted EPS $0.31 vs. $0.26 | 101 | 1 |
6.17 Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results | 102 | 1 |
6.18 Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results | 103 | 2 |
6.19 Jul 21, 2016: Ossur: Q2 Results 2016 | 105 | 1 |
6.20 Jul 08, 2016: Mobius Bionics to Bring DEKA s LUKE Prosthetic Arm to Market | 105 | 1 |
6.21 Jul 08, 2016: Wearable neuromuscular device may help reduce ACL injuries in female soccer players | 106 | 1 |
6.22 Jul 01, 2016: NacImBio presented its prosthetic and orthopedic products at the exhibition in Tula | 107 | 1 |
6.23 Jun 30, 2016: Bionik Laboratories Reports Fiscal Year Ended 2016 Financial Results and Provides Business Update | 107 | 1 |
6.24 Jun 19, 2016: Body Organ Biomedical to Raise USD5.4 Million in Rights Offering of Shares | 108 | 1 |
6.25 Jun 14, 2016: Ability Dynamics announces Distribution Partnership With Korean-Based Sunglim Trading for RUSH HiPro | 108 | 1 |
6.26 Jun 14, 2016: Ability Dynamics announces Distribution Partnership With Korean-Based Sunglim Trading for RUSH LoPro | 109 | 1 |
6.27 Jun 13, 2016: Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares | 109 | 1 |
6.28 Jun 10, 2016: Quebec City's Firefighters and Emergency Response Team Will Test B-TEMIA's Dermoskeleton | 109 | 1 |
6.29 Jun 09, 2016: Amplitude Surgical files for American FDA 510(k) approval for its posterior-stabilized knee prosthesis ANATOMIC | 110 | 1 |
6.30 Jun 07, 2016: Zimmer Biomet Plans to Raise USD750 Million in Public Offering of Notes | 110 | 1 |
6.31 May 31, 2016: Ergoresearch announce the nomination of an Executive Vice-President | 110 | 1 |
6.32 May 27, 2016: Ergoresearch Reports its Results for the Quarter Ended March 31, 2016 | 111 | 1 |
6.33 May 10, 2016: Mazor Robotics Reports First Quarter Financial Results | 111 | 1 |
6.34 Apr 26, 2016: Freedom Innovations Board Names David A. Smith Chairman &CEO Maynard Carkhuff Named Vice Chairman | 112 | 1 |
6.35 Apr 11, 2016: Ossur Acquires Touch Bionics for USD39 Million | 112 | 1 |
6.36 Apr 05, 2016: Ability Dynamics Introduces the Dynamic, Ultra Low Profile RUSH ROVER for Active Amputees | 113 | 1 |
6.37 Apr 04, 2016: HCi Viocare to Raise up to USD34 Million in Public Offering of Shares | 113 | 1 |
6.38 Mar 21, 2016: Bionik Laboratories Reports 2015 Financial Results and Provides Business Update | 113 | 2 |
6.39 Mar 17, 2016: LIM Innovations Gets Medicare Approval | 115 | 1 |
6.40 Mar 16, 2016: India Life Sciences Fund Invests in Biorad Medisys | 115 | 1 |
6.41 Mar 03, 2016: DT MedTech Acquires Rights to Hintermann Series of Lower Extremity Device Product Line | 115 | 1 |
6.42 Mar 02, 2016: Breg Unveils Genesis Mid-Calf Walker Boot | 116 | 1 |
6.43 Feb 29, 2016: Second Quarter Results ended December 31, 2015 - Ergoresearch reports its results for the quarter ended December 31, 2015 | 116 | 1 |
6.44 Feb 18, 2016: Mazor Robotics Reports Record Fourth Quarter Financial Results | 117 | 1 |
6.45 Feb 02, 2016: Ossur Hf: Q4&FY Results 2015 | 118 | 1 |
6.46 Jan 25, 2016: Global Prosthetics Leaders Ossur and Ottobock Partner on Historic Research Trust Fund at the University of Iceland | 119 | 1 |
6.47 Jan 21, 2016: Synoste Raises Funds in Series A Financing Round | 119 | 1 |
6.48 Jan 15, 2016: Ossur Receives EPSRC Grant | 120 | 1 |
6.49 Jan 11, 2016: Bio2 Technologies Announces Receipt of FDA 510(k) Clearance for a Fusion Implant System for Extremities Surgery | 120 | 1 |
6.50 Dec 09, 2015: Collaboration between Ottobock and BionX | 120 | 1 |
7 Appendix | 121 | 4 |
7.1 Methodology | 121 | 2 |
7.2 About GlobalData | 123 | 1 |
7.3 Contact Us | 124 | 1 |
7.4 Disclaimer | 124 | 1 |